135 related articles for article (PubMed ID: 27739315)
1. [Expression of ATP-binding Cassette Proteins Pgp, MRP1, and MRP3 in Malignant and Benign Ovarian Lesions].
Sedláková I; Laco J; Tošner J; Špaček J
Klin Onkol; 2016; 29(5):358-363. PubMed ID: 27739315
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic significance of Pgp, MRP1, and MRP3 in ovarian cancer patients].
Sedláková I; Laco J; Tošner J; Špaček J
Ceska Gynekol; 2015 Dec; 80(6):405-13. PubMed ID: 26741154
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of the resistance proteins LRP, Pgp, MRP1, MRP3, and MRP5 in epithelial ovarian cancer.
Sedláková I; Laco J; Caltová K; Červinka M; Tošner J; Řezáč A; Špaček J
Int J Gynecol Cancer; 2015 Feb; 25(2):236-43. PubMed ID: 25594141
[TBL] [Abstract][Full Text] [Related]
4. [Drug resistance proteins LRP, Pgp, MRP1, MRP3 and MRP5 in ovarian cancer patients].
Sedláková I; Laco J; Tošner J; Spaček J; Cermáková E
Ceska Gynekol; 2013 Dec; 78(6):545-53. PubMed ID: 24372433
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.
Izquierdo MA; van der Zee AG; Vermorken JB; van der Valk P; Beliën JA; Giaccone G; Scheffer GL; Flens MJ; Pinedo HM; Kenemans P
J Natl Cancer Inst; 1995 Aug; 87(16):1230-7. PubMed ID: 7563169
[TBL] [Abstract][Full Text] [Related]
6. ATP-binding cassette superfamily transporter gene expression in human primary ovarian carcinoma.
Ohishi Y; Oda Y; Uchiumi T; Kobayashi H; Hirakawa T; Miyamoto S; Kinukawa N; Nakano H; Kuwano M; Tsuneyoshi M
Clin Cancer Res; 2002 Dec; 8(12):3767-75. PubMed ID: 12473588
[TBL] [Abstract][Full Text] [Related]
7. [Proteins of resistance and drug resistance in ovarian carcinoma patients].
Sedláková I; Laco J; Tošner J; Caltová K; Cervinka M; Rezáč A; Spaček J; Skapinec P
Klin Onkol; 2012; 25(6):457-63. PubMed ID: 23301649
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance-associated biomarkers PGP, GST-pi, Topo-II and LRP as prognostic factors in primary ovarian carcinoma.
Lu D; Shi HC; Wang ZX; Gu XW; Zeng YJ
Br J Biomed Sci; 2011; 68(2):69-74. PubMed ID: 21706917
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques.
Jekerle V; Klinkhammer W; Scollard DA; Breitbach K; Reilly RM; Piquette-Miller M; Wiese M
Int J Cancer; 2006 Jul; 119(2):414-22. PubMed ID: 16646006
[TBL] [Abstract][Full Text] [Related]
10. MRP3, BCRP, and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemia.
Benderra Z; Faussat AM; Sayada L; Perrot JY; Tang R; Chaoui D; Morjani H; Marzac C; Marie JP; Legrand O
Clin Cancer Res; 2005 Nov; 11(21):7764-72. PubMed ID: 16278398
[TBL] [Abstract][Full Text] [Related]
11. Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.
Calatozzolo C; Gelati M; Ciusani E; Sciacca FL; Pollo B; Cajola L; Marras C; Silvani A; Vitellaro-Zuccarello L; Croci D; Boiardi A; Salmaggi A
J Neurooncol; 2005 Sep; 74(2):113-21. PubMed ID: 16193381
[TBL] [Abstract][Full Text] [Related]
12. Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats.
Cherrington NJ; Hartley DP; Li N; Johnson DR; Klaassen CD
J Pharmacol Exp Ther; 2002 Jan; 300(1):97-104. PubMed ID: 11752103
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the binding of the tricyclic isoxazole photoaffinity label LY475776 to multidrug resistance associated protein 1 (MRP1) orthologs and several ATP- binding cassette (ABC) drug transporters.
Dantzig AH; Shepard RL; Pratt SE; Tabas LB; Lander PA; Ma L; Paul DC; Williams DC; Peng SB; Slapak CA; Godinot N; Perry WL
Biochem Pharmacol; 2004 Mar; 67(6):1111-21. PubMed ID: 15006547
[TBL] [Abstract][Full Text] [Related]
14. [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma].
Katsaros D; Fracchioli S; Arts HJ; de Vries EG; Danese S; Richiardi G; Arisio R; Gordini G; Van der Zee AG; Suurmeijer AJ; Massobrio M
Minerva Ginecol; 1999 Dec; 51(12):463-70. PubMed ID: 10767994
[TBL] [Abstract][Full Text] [Related]
15. Expression and role of PGP, BCRP, MRP1 and MRP3 in multidrug resistance of canine mammary cancer cells.
Pawłowski KM; Mucha J; Majchrzak K; Motyl T; Król M
BMC Vet Res; 2013 Jun; 9():119. PubMed ID: 23773525
[TBL] [Abstract][Full Text] [Related]
16. Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade.
Komdeur R; Plaat BE; van der Graaf WT; Hoekstra HJ; Hollema H; van den Berg E; Zwart N; Scheper RJ; Molenaar WM
Eur J Cancer; 2003 May; 39(7):909-16. PubMed ID: 12706359
[TBL] [Abstract][Full Text] [Related]
17. High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease.
Ros JE; Libbrecht L; Geuken M; Jansen PL; Roskams TA
J Pathol; 2003 Aug; 200(5):553-60. PubMed ID: 12898590
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance proteins expression in glioma patients with epilepsy.
Calatozzolo C; Pollo B; Botturi A; Dinapoli L; Carosi M; Salmaggi A; Maschio M
J Neurooncol; 2012 Oct; 110(1):129-35. PubMed ID: 22832898
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.
Haga S; Hinoshita E; Ikezaki K; Fukui M; Scheffer GL; Uchiumi T; Kuwano M
Jpn J Cancer Res; 2001 Feb; 92(2):211-9. PubMed ID: 11223551
[TBL] [Abstract][Full Text] [Related]
20. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.
Kovalev AA; Tsvetaeva DA; Grudinskaja TV
Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
